A few months ago we reported that 3D Systems has entered into a partnership with the Belgian biotechnology company Antleron, and thus entered the 3D bioprinting industry. Now the American giant of 3D printing technologies, strengthening its position in this area, decided to cooperate with the Israeli technology start-up, CollPlant. The business experience of 3D Systems and the specialized knowledge of CollPlant will allow the implementation of the project in the field of 3D printing of tissue scaffolds.
CollPlant is one of the pioneers of the bioprinting industry. Their substance called rhCollagen (a recombination of human collagen) has a chance to change the face of modern transplantation, being an alternative to the synthetic materials used so far. The Israeli company, together with 3D Systems, will look for applications for proprietary material, creating scouts and attempting 3D printing from living tissues. The goal of the project is to create a comprehensive solution for the needs of regenerative medicine.
Chuck Hull, co-founder of 3D Systems, says that incremental technologies have a chance to play a key role in the development of regenerative medicine. The combination of the potential of both companies in the implementation of the project in the field of 3D printing can result in innovative solutions that will find application in the world of modern medicine.
Yehiel Tal, CEO of CollPlant emphasizes that their proprietary rhCollagen has appropriate building properties, which can be successfully used as a bioblock. He also adds that the cooperation opens up completely new possibilities for CollPlant, and in the long run may result in the commercialization of their proprietary solutions.
The main article’s photo presents the first results of the cooperation. The picture shows 3D bi-printed soft tissues created with the use of a 3D Systems device and rhCollagen material.